πŸ‡ΊπŸ‡Έ FDA
Patent

US 10562938

Theragnostic particles

granted A61KA61K38/177

Quick answer

US patent 10562938 (Theragnostic particles) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/177